Michael Karin

27PUBLICATIONS
163CO-AUTHORS
Food properties (incl. characteristics and health benefits)Predictive and prognostic markersHaematological tumoursInnate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 21, 2026
A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

|Aug 11, 2026
Hepatocyte-intrinsic ER stress and NRF2 initiate primary sclerosing cholangitis, providing therapeutic insights.

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Jan 21, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Laura Antonucci, Kosuke Watari, Yechen Feng

|Oct 24, 2025
Obesity-related microbial dysbiosis as a potential modulator of tumour progression.

Omar Mokhashi, Jaideep Chakladar, Wei Tse Li

|Aug 20, 2025
mAChR4 suppresses liver disease via GAP-induced antimicrobial immunity.

Cristina Llorente, Fernanda Raya Tonetti, Ryan Bruellman

Pageof 5

Frequent Collaborators

8 joint publications

Kosuke Watari

4 joint publications

Li Gu

3 joint publications

Beicheng Sun

3 joint publications

Shuvro Prokash Nandi